International Journal of Hematology and Oncology
2019 , Vol 29 , Num 3
Hacer Berna AFACAN OZTURK, Abdulkerim YILDIZ, Murat ALBAYRAK, Cigdem PALA, Senem MARAL, Mesude FALAY
CD25 Expression is Associated with Autoimmunity in Patients with CLL. UHOD , 2019 , 29 , 123-129
Gokhan YAPRAK, Alaattin OZEN, Fuzuli TUGRUL, Sule OZUGUR, Naciye ISIK Is There Any Prognostic Significance of the Level of Change in SUVmax after SBRT in Patients with Early Stage NSCLC?. UHOD , 2019 , 29 , 130-138
Goksen INANC IMAMOGLU, Tulay EREN, Nuriye YILDIRIM OZDEMIR, Cengiz KARACIN, Sertac CIMEN, Ebru CILBIR, Dogan YAZILITAS Do Patient Characteristics And Duration of Response to Hormonal Therapy Predict Outcomes of Post-Docetaxel Abirateron Acetate Treatment in Prostate Cancer?. UHOD , 2019 , 29 , 139-146
Oztun TEMELLI, Mehmet DEMIRTAS, Berat Tugrul UGURLU, Harika Gozukara BAG Integral Dose and Dosimetric Comparison of NeoAdjuvant Simultaneous Integrated Boost (SIB) Radiotherapy Technique for Rectal Cancer Using Intensity-Modulated Radiotherapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), and Helical Tomotherapy (HT). UHOD , 2019 , 29 , 147-156
Ayse OZKAN, Ibrahim BAYRAM, Gulay SEZGIN, Can ACIPAYAM, Serhan KUPELI, Atila TANYELI Lamin Protein Gene Expression in Childhood Acute Lymphoblastic Leukemia. UHOD , 2019 , 29 , 157-167
Veli SUNAR, Vakkas KORKMAZ, Zafer ARIK, Bulent OZDAL, Yaprak ENGIN USTUN Retrospective Analysis of Gestational Trophoblastic Neoplasia: Single Center Experience. UHOD , 2019 , 29 , 168-175
Hamit BASARAN, Mustafa CENGIZ, Gozde YAZICI, Nilda SUSULU, Sercan AKSOY, Ali Sefik HOSAL, Ibrahim H. GULLU, Gokhan OZYIGIT Neoadjuvant Chemotherapy Improves Survival in Patients with Locally Advanced Nasopharyngeal Carcinoma. UHOD , 2019 , 29 , 176-185
Bartosz PULA, Krzysztof JAMROZIAK Ibrutinib Therapy for Chronic Lymphocytic Leukemia Complicated with Secondary Serous Adenocarcinoma of the Peritoneum. UHOD , 2019 , 29 , 186-189
Gokhan YAPRAK, Alaattin OZEN, Fuzuli TUGRUL, Sule OZUGUR, Naciye ISIK Is There Any Prognostic Significance of the Level of Change in SUVmax after SBRT in Patients with Early Stage NSCLC?. UHOD , 2019 , 29 , 130-138
Goksen INANC IMAMOGLU, Tulay EREN, Nuriye YILDIRIM OZDEMIR, Cengiz KARACIN, Sertac CIMEN, Ebru CILBIR, Dogan YAZILITAS Do Patient Characteristics And Duration of Response to Hormonal Therapy Predict Outcomes of Post-Docetaxel Abirateron Acetate Treatment in Prostate Cancer?. UHOD , 2019 , 29 , 139-146
Oztun TEMELLI, Mehmet DEMIRTAS, Berat Tugrul UGURLU, Harika Gozukara BAG Integral Dose and Dosimetric Comparison of NeoAdjuvant Simultaneous Integrated Boost (SIB) Radiotherapy Technique for Rectal Cancer Using Intensity-Modulated Radiotherapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), and Helical Tomotherapy (HT). UHOD , 2019 , 29 , 147-156
Ayse OZKAN, Ibrahim BAYRAM, Gulay SEZGIN, Can ACIPAYAM, Serhan KUPELI, Atila TANYELI Lamin Protein Gene Expression in Childhood Acute Lymphoblastic Leukemia. UHOD , 2019 , 29 , 157-167
Veli SUNAR, Vakkas KORKMAZ, Zafer ARIK, Bulent OZDAL, Yaprak ENGIN USTUN Retrospective Analysis of Gestational Trophoblastic Neoplasia: Single Center Experience. UHOD , 2019 , 29 , 168-175
Hamit BASARAN, Mustafa CENGIZ, Gozde YAZICI, Nilda SUSULU, Sercan AKSOY, Ali Sefik HOSAL, Ibrahim H. GULLU, Gokhan OZYIGIT Neoadjuvant Chemotherapy Improves Survival in Patients with Locally Advanced Nasopharyngeal Carcinoma. UHOD , 2019 , 29 , 176-185
Bartosz PULA, Krzysztof JAMROZIAK Ibrutinib Therapy for Chronic Lymphocytic Leukemia Complicated with Secondary Serous Adenocarcinoma of the Peritoneum. UHOD , 2019 , 29 , 186-189